Legacy signals
Legacy popularity: 1,436 legacy views
Well, “someone” (big media) finally asked the obvious question “what is going on with these statin drugs?”nnFor those of you who have worked with me, you already know that I have some ideas about cholesterol, heart health and statin drugs that vary from the conventional “party line.” I have worked diligently in my practice to offer alternative ways of thinking about cardiovascular health, cholesterol and healthier ways of reducing cholesterol, when necessary.nnWhy? There have been some serious health risks, documented by the drug manufacturers themselves, in association with the use of these drugs. Additionally, there are many people taking these drugs that suffer significant reduction in quality of life upon taking the statins. Further, so far no one has been able to present compelling evidence that these drugs are really doing anything very useful for those that are willing to take on the health risks and quality of life challenges that go along with taking these drugs.nnBusiness Week magazine published an eye-opening article on that very issue. And as one person put it to me “you will be very happy to read this.” nnThe news is a great disappointment to those that were taking these drugs in hopes of achieving some miraculous reduction in their risk of a dangerous cardiovascular event. On the other hand, it is encouraging to those that always suspected that perhaps there could be something else, something more, something safer, on that health horizon for them. It gives us all the renewed confidence to do our own thinking on this topic, to listen to our “gut” on this issue, and to think twice before taking something that may do more harm than good.nnMost of the people that I work with know that there are serious concerns over the statin drugs, but at the same time they are also afraid to go against the conventional recommendation that these drugs are going to save them from a heart attack. It has been a struggle, emotionally, to doubt that these drugs will actually deliver on that front. On one hand it feels like a risk to take them and on the other hand it feels like a risk not to take them. For the person making that decision, it feels like being caught between a rock and a hard place.nnFortunately, Naturopathic Medicine has so much to offer as we seek to enhance our cardiovascular health and reduce our risks associated with the cardiovascular system. The explosion of research in nutritional and herbal medicine over the last 25 years scientifically validates our inclination to lean in that direction. Further, in the interest of first do no harm it is just smarter to start with a therapy that does not carry the risks and side effects often associated with pharmaceutical agents and that simultaneously enhances our overall health and our quality of life. nnIf you, or someone you care about, have concerns about cardiovascular health – and are working with your prescribing physician to take a fresh look at your statin prescription, consider incorporating Naturopathic Medicine into that discussion. Conventional testing such as blood tests for cholesterol levels, homocysteine, cardio CRP, and calcium scored heart scans can give you insight into your success so that you can monitor the effectiveness of the therapeutic choices you make. Further, new forms of testing are being looked at as more accurate for determining risk, such as the Rho-Kinase enzyme – which seems to be more effective at predicting risk than cholesterol levels. nnWe have so much to work with, and it feels so good to accomplish your cardiovascular goals by improving your overall health. Feel free to contact us and make an appointment with me to begin this important heart-healthy work for a great 2008!nnWhat did that Business Week article have to say? Here is the take home message:nn- Statins do reduce LDL cholesterol, but the data that they have a significant impact on reduction of heart attacks relative to their cost is minimaln- Without multiple risk factors for heart attack (smoking, blood pressure, obesity, diabetes, high cholesterol) approximately 250 people have to take statin drugs, for years, at a cost of over $1,000 per year in order to prevent one heart attack – in other words we are spending over $750,000 to prevent one heart attack with the use of statins. n- Why are we so aggressively trying to lower cholesterolno Recommendations from the NCEP - National Cholesterol Education Program, lowered the targets for LDL cholesterol, which increased the number of people who were “candidates” for statin drugsno However, 8 of the 9 people on the NCEP had financial ties to pharmaceutical companies that sell statin drugsn- NTT – Number to Treat – the number of people that need to be treated to prevent one heart attackno For statins NTT is 100 for people with multiple risk factors and roughly 250 for those with just high cholesteroln- Perspective from other countries:no Spain has similar levels of LDL cholesterol to the US, but less than half the rate of heart diseaseno Switzerland has higher levels of LDL than the US, with lower rates of heart diseaseno Australian aborigines have lower cholesterol levels than the US, but higher rates of heart diseasen- Rho-kinase – an enzyme marker linked to inflammation in the arteries, may be a better indicator of heart disease riskn